Financial Performance - For the nine months ended September 30, 2022, the group achieved a consolidated revenue of RMB 304,972,430, a decrease of 14.61% compared to RMB 357,140,151 for the same period last year[6] - The consolidated gross profit for the nine months ended September 30, 2022, was RMB 11,188,179, representing a significant decrease of 71.03% from RMB 38,625,967 in the previous year[6] - The loss attributable to equity holders for the nine months ended September 30, 2022, was RMB 21,627,090, compared to a profit of RMB 1,823,539 for the same period last year, resulting in a loss per share of RMB 1.142[6] - Revenue from fertilizer products and elderly care services for the nine months ended September 30, 2022, was RMB 304,972,430, down from RMB 357,140,151 in the previous year[9] - The group reported a pre-tax loss of RMB 21,852,487 for the nine months ended September 30, 2022, compared to a profit of RMB 1,993,104 in the previous year[7] - The total operating expenses and net losses for the nine months ended September 30, 2022, were RMB 2,905,191, compared to RMB 595,667 in the same period last year[7] - The comprehensive gross profit for the same period was RMB 11,188,179, reflecting a significant decrease of 71.03% from RMB 38,625,967 in 2021[31] - The operating comprehensive gross profit margin was 3.67%, down 7.15% from 10.82% in the previous year[31] - The sales and distribution costs decreased by 45.01% to RMB 9,368,063 from RMB 17,036,248 in 2021[31] - Research and administrative expenses increased by 19.72% to RMB 22,477,429 compared to RMB 18,774,490 in the previous year[31] - Financing costs surged by 189.21% to RMB 4,100,365 from RMB 1,417,792 in 2021[31] - Basic loss per share was RMB 1.142, while the previous year reported earnings per share of RMB 0.096[15] Corporate Governance - The board of directors does not recommend the payment of any dividend for the nine months ended September 30, 2022[6] - The company has not reported any new product developments or market expansion strategies during this period[6] - The company appointed Mr. Qin Wenhua as Co-CEO on September 6, 2022, with Ms. Sun Li transitioning from CEO to Co-CEO[45] - No competition or potential conflicts of interest were reported among the company's directors, supervisors, or management shareholders as of September 30, 2022[46] - The audit committee consists of three independent non-executive directors, with Mr. Li Xudong serving as the chairman due to his professional accounting qualifications and auditing experience[47] - No new share option plans were approved during the period ending September 30, 2022[48] - The company did not enter into any management contracts for overall business or any major business during the period ending September 30, 2022[49] - The board of directors believes that the company has complied with all provisions of the corporate governance code, except for the requirement that the roles of chairman and CEO should be separate[50] - Ms. Sun Li was appointed as co-CEO, while Mr. Qin Wenhua was also appointed as co-CEO, maintaining continuity and stability in company policies[50] - The company aims to enhance corporate governance transparency and independence in the near future[50] Market and Industry Insights - The aging population in China, with 264 million people aged 60 and above, presents significant growth potential for the elderly care services industry[36] - The company plans to enhance marketing management and adjust product structure to improve market share in the compound fertilizer sector[35] Shareholder Information - As of September 30, 2022, the company has a total of 300,000,000 shares held by each of the directors, accounting for 15.83% of the issued shares[37] - Major shareholders include Tianjin Economic and Technological Development Zone State-owned Assets Management Co., Ltd. with 182,500,000 shares (9.63%) and Shenzhen Xiangyong Investment Co., Ltd. with 180,000,000 shares (9.50%) as of September 30, 2022[41] - The company has not achieved the profit guarantee for SJKGC for the fiscal years 2017, 2018, and 2019, with net profits of approximately $2,922,000, $305,000, and $411,000 respectively, all below the guaranteed amount of $5,390,000[44][45] Reporting and Availability - The report will be available for at least seven days on the GEM website and the company's website[51]
泰达生物(08189) - 2022 Q3 - 季度财报